BidaskClub upgraded shares of Surgery Partners (NASDAQ:SGRY) from a hold rating to a buy rating in a report released on Tuesday morning.

Several other equities research analysts have also commented on SGRY. Royal Bank of Canada increased their price objective on shares of Surgery Partners from $18.00 to $20.00 and gave the company an outperform rating in a research note on Friday, August 10th. Stifel Nicolaus upgraded shares of Surgery Partners from a sell rating to a hold rating and set a $15.00 price objective for the company in a research note on Thursday, June 28th. Leerink Swann increased their price objective on shares of Surgery Partners from $20.00 to $25.00 and gave the company an outperform rating in a research note on Monday, August 13th. Finally, ValuEngine upgraded shares of Surgery Partners from a sell rating to a hold rating in a research note on Thursday, June 21st. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The stock currently has a consensus rating of Buy and an average price target of $19.43.

NASDAQ:SGRY opened at $17.30 on Tuesday. The company has a quick ratio of 1.44, a current ratio of 1.59 and a debt-to-equity ratio of 1.69. The stock has a market capitalization of $870.46 million, a price-to-earnings ratio of -20.83 and a beta of 1.78. Surgery Partners has a 52 week low of $7.10 and a 52 week high of $19.95.

Surgery Partners (NASDAQ:SGRY) last posted its quarterly earnings data on Thursday, August 9th. The company reported ($0.18) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.25) by $0.07. The firm had revenue of $444.78 million during the quarter, compared to analyst estimates of $428.50 million. Surgery Partners had a negative net margin of 5.56% and a negative return on equity of 1.67%. The company’s revenue for the quarter was up 54.2% on a year-over-year basis. During the same quarter last year, the business posted ($0.09) EPS. equities analysts forecast that Surgery Partners will post -0.55 earnings per share for the current year.

Several hedge funds have recently modified their holdings of the company. US Bancorp DE increased its stake in shares of Surgery Partners by 76.6% during the 2nd quarter. US Bancorp DE now owns 7,328 shares of the company’s stock worth $109,000 after purchasing an additional 3,179 shares during the last quarter. Schwab Charles Investment Management Inc. increased its stake in shares of Surgery Partners by 3.4% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 102,669 shares of the company’s stock worth $1,530,000 after purchasing an additional 3,336 shares during the last quarter. BlackRock Inc. increased its stake in shares of Surgery Partners by 0.5% during the 4th quarter. BlackRock Inc. now owns 1,306,021 shares of the company’s stock worth $15,804,000 after purchasing an additional 7,029 shares during the last quarter. Bank of New York Mellon Corp increased its stake in shares of Surgery Partners by 8.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 93,771 shares of the company’s stock worth $1,397,000 after purchasing an additional 7,332 shares during the last quarter. Finally, MetLife Investment Advisors LLC purchased a new stake in shares of Surgery Partners during the 1st quarter worth approximately $164,000. Institutional investors own 97.64% of the company’s stock.

Surgery Partners Company Profile

Surgery Partners, Inc, through its subsidiaries, operates surgical facilities in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.

Further Reading: Do closed-end mutual funds pay dividends?

Analyst Recommendations for Surgery Partners (NASDAQ:SGRY)

Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.